Hashimoto’s thyroiditis in patients with normal thyroid-stimulating hormone levels

References

• Hayashi N, Tamaki N, Konishi J et al. Sonography of Hashimoto’s thyroiditis. J. Clin. Ultrasound14, 123–126 (1986).
   PubMed Web of Science ®Google Scholar
• Jenkins RC, Weetman AP. Disease associations with autoimmune thyroid disease. Thyroid12, 977–988 (2002).
   PubMed Web of Science ®Google Scholar
• Bianchi GP, Zaccheroni V, Solaroli E et al. Health-related quality of life in patients with thyroid disorders. Qual. Life Res.13, 45–54 (2004).
   PubMedGoogle Scholar
• Ott J, Promberger R, Kober F et al. Hashimoto’s thyroiditis affects symptom load and quality of life unrelated to hypothyroidism: a prospective case–control study in women undergoing thyroidectomy for benign goiter. Thyroid21, 161–167 (2011).
   PubMed Web of Science ®Google Scholar
• Dickson A, Toft A, O’Carroll RE. Neuropsychological functioning, illness perception, mood and quality of life in chronic fatigue syndrome, autoimmune thyroid disease and healthy participants. Psychol. Med.39, 1567–1576 (2009).
   PubMed Web of Science ®Google Scholar
• Boelaert K, Newby PR, Simmonds MJ et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am. J. Med.123, e1831–e1839 (2010).
   Google Scholar
• Franchini M, Lippi G, Manzato F et al. Thyroid-associated autoimmune coagulation disorders. J. Thromb. Thrombolysis29, 87–91 (2010).
   PubMed Web of Science ®Google Scholar
• Bozec A, Lassalle S, Hofman V et al. The thyroid gland: a crossroad in inflammation-induced carcinoma? An ongoing debate with new therapeutic potential. Curr. Med. Chem.17, 3449–3461 (2010).
   PubMedGoogle Scholar
• Nikiforov YE. RET/PTC rearrangement – a link between Hashimoto’s thyroiditis and thyroid cancer.or not. J. Clin. Endocrinol. Metab.91(6), 2040–2042 (2006).
   PubMedGoogle Scholar
• Pacini F, Vorontsova T, Demidchik EP et al. Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France. J. Clin. Endocrinol. Metab.82(11), 3563–3569 (1997).
   PubMed Web of Science ®Google Scholar
• Ott J, Meusel M, Schultheis A et al. The incidence of lymphocytic thyroid infiltration and Hashimoto’s thyroiditis increased in patients operated for benign goiter over a 31-year period. Virchows Arch.459, 277–281 (2011).
   PubMed Web of Science ®Google Scholar
• Mukasa K, Noh JY, Kunii Y et al. Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases. Thyroid21, 37–41 (2011).
   PubMedGoogle Scholar
• Pradeep PV, Ragavan M, Ramakrishna BA et al. Surgery in Hashimoto’s thyroiditis: indications, complications, and associated cancers. J. Postgrad. Med.57, 120–122 (2011).
   PubMedGoogle Scholar
• Ganie MA, Marwaha RK, Aggarwal R et al. High prevalence of polycystic ovary syndrome characteristics in girls with euthyroid chronic lymphocytic thyroiditis: a case–control study. Eur. J. Endocrinol.162, 1117–1122 (2010).
   PubMed Web of Science ®Google Scholar
• Gleicher N, Barad D, Weghofer A. Functional autoantibodies, a new paradigm in autoimmunity? Autoimmun. Rev.7, 42–45 (2007).
   PubMed Web of Science ®Google Scholar
• Ott J, Aust S, Kurz C et al. Elevated antithyroid peroxidase antibodies indicating Hashimoto’s thyroiditis are associated with the treatment response in infertile women with polycystic ovary syndrome. Fertil. Steril.94, 2895–2897 (2010).
   PubMed Web of Science ®Google Scholar
• Matalon ST, Blank M, Ornoy A et al. The association between anti-thyroid antibodies and pregnancy loss. Am. J. Reprod. Immunol.45, 72–77 (2001).
   PubMedGoogle Scholar
• Muller AF, Berghout A. Consequences of autoimmune thyroiditis before, during and after pregnancy. Minerva Endocrinol.28, 247–254 (2003).
   PubMedGoogle Scholar
• Rovelli R, Vigone MC, Giovanettoni C et al. Newborn of mothers affected by autoimmune thyroiditis: the importance of thyroid function monitoring in the first months of life. Ital. J. Pediatr.36, 24–28 (2010).
   PubMed Web of Science ®Google Scholar
• Mocellin R, Walterfang M, Velakoulis D. Hashimoto’s encephalopathy: epidemiology, pathogenesis and management. CNS Drugs21, 799–811 (2007).
   PubMed Web of Science ®Google Scholar
• Tamagno G, Federspil G, Murialdo G. Clinical and diagnostic aspects of encephalopathy associated with autoimmune thyroid disease (or Hashimoto’s encephalopathy). Intern. Emerg. Med.1, 15–23 (2006).
   PubMed Web of Science ®Google Scholar
• Schiess N, Pardo CA. Hashimoto’s encephalopathy. Ann. NY Acad. Sci.1142, 254–265 (2008).
   PubMed Web of Science ®Google Scholar
• Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy syndrome or myth? Arch. Neurol.60, 164–171 (2003).
   PubMedGoogle Scholar
• Watemberg N, Greenstein D, Levine A. Encephalopathy associated with Hashimoto thyroiditis: pediatric perspective. J. Child Neurol.21, 1–5 (2006).
   PubMed Web of Science ®Google Scholar
• Aydin-Ozemir Z, Tüzün E, Baykan B et al. Autoimmune thyroid encephalopathy presenting with epilepsia partialis continua. Clin. EEG Neurosc.37, 204–209 (2006).
   PubMedGoogle Scholar
• Maydell B, Kopp M, Komorowski GV et al. Hashimoto encephalopathy-is it underdiagnosed in pediatric patients? Neuropediatrics33, 86–89 (2002).
   PubMedGoogle Scholar
• Marshall GA, Doyle JJ. Long-term treatment of Hashimoto’s encephalopathy. J. Neuropsychiatry Clin. Neurosci.18, 14–20 (2006).
   PubMedGoogle Scholar
• Vasconcellos E, Pina-Garza JE, Fakhoury T, Fenichel GM. Pediatric manifestations of Hashimoto’s encephalopathy. Pediatr. Neurol.20, 394–398 (1999).
   PubMedGoogle Scholar
• Müssig K, Leyhe T, Holzmüller S et al. Increased prevalence of antibodies to central nervous system tissue and gangliosides in Hashimoto’s thyroiditis compared to other thyroid illnesses. Psychoneuroendocrinology34, 1252–1256 (2009).
   PubMedGoogle Scholar
• Papi G, Guidetti G, Corsello SM et al. The association between benign paroxysmal positional vertigo and autoimmune chronic thyroiditis is not related to thyroid status. Thyroid20, 237–238 (2010).
   PubMedGoogle Scholar
• Akgul E, Kutuk U, Ertek S et al. Cardiac autonomic function and global left ventricular performance in autoimmune eauthyroid chronic thyroiditis: is treatment necessary at the euthyroid stage? Echocardiography28, 15–21 (2011).
   PubMed Web of Science ®Google Scholar
• Evangelopoulou ME, Alevizaki M, Toumanidis S et al. Mitral valve prolapse in autoimmune thyroid disease: an index of systemic autoimmunity? Thyroid9, 973–977 (1999).
   PubMedGoogle Scholar
• Evangelopoulos ME, Toumanidis S, Sotou D et al. Mitral valve prolapse in young healthy individuals. An early index of autoimmunity? Lupus18, 436–540 (2009).
   PubMedGoogle Scholar
• Saliba W, El Fakih R, Shaheen W. Heart failure secondary to selenium deficiency, reversible after supplementation. Int. J. Cardiol. 28, 141(2), e26–e27 (2010).
   PubMed Web of Science ®Google Scholar
• Ebert EC. The thyroid and the gut. J. Clin. Gastroenterol.44, 402–406 (2010).
   PubMedGoogle Scholar
• Bazzichi L, Rossi A, Zirafa C et al. Thyroid autoimmunity may represent a predisposition for the development of fibromyalgia? Rheumatol. Int.32, 335–341 (2012).
   PubMedGoogle Scholar
• Benvenga S, Trimarchi F. Changed presentation of Hashimoto’s thyroiditis in North-Eastern Sicily and Calabria (Southern Italy) based on a 31-year experience. Thyroid18, 429–441 (2008).
   PubMed Web of Science ®Google Scholar
• Rizzo M, Rossi RT, Bonaffini O et al. Increased annual frequency of Hashimoto’s thyroiditis between years 1988 and 2007 at a cytological unit of Sicily. Ann. Endocrinol. (Paris)71, 525–534 (2010).
   PubMed Web of Science ®Google Scholar
• Carayanniotis G. Molecular parameters linking thyroglobulin iodination with autoimmune thyroiditis. Hormones (Athens)10, 27–35 (2011).
   PubMedGoogle Scholar
• McManus C, Luo J, Sippel R et al. Should patients with symptomatic Hashimoto’s thyroiditis pursue surgery? J. Surg. Res.170, 52–55 (2011).
   PubMedGoogle Scholar
• Tektonidou MG, Margarita A, Vlachoyiannopoulos P et al. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases. Ann. Rheum. Dis.63, 1159–1161 (2004).
   PubMed Web of Science ®Google Scholar
• Biró E, Szekanecz Z, Czirják L et al. Association of systemic and thyroid autoimmnune diseases. Clin. Rheumatol.25, 240–245 (2006).
   PubMed Web of Science ®Google Scholar
• Gärtner R, Gasnier BC, Dietrich JW et al. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J. Clin. Endocrinol. Metab.87, 1687–1691 (2002).
   PubMed Web of Science ®Google Scholar
• Gärtner R, Gasnier BC. Selenium in the treatment of autoimmune thyroiditis. Biofactors19, 65–170 (2003).
   Google Scholar
• Karanikas G, Schuetz M, Kontur S et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid18, 7–12 (2008).
   PubMed Web of Science ®Google Scholar
• Toulis KA, Anastasilakis AD, Tzellos TG, Goulis DG, Kouvelas D. Selenium supplementation in the treatment of Hashimoto’s thyroiditis: a systematic review and a meta-analysis. Thyroid20, 1163–1173 (2010).
   PubMed Web of Science ®Google Scholar
• Köhrle J, Gärtner R. Selenium and thyroid. Best Pract. Res. Clin. Endocrinol. Metab.23, 815–827 (2009).
   PubMed Web of Science ®Google Scholar
• Padberg S, Heller K, Usadel KH et al. One-year prophylactic treatment of euthyroid Hashimoto’s thyroiditis patients with levothyroxine: is there a benefit? Thyroid11, 249–255 (2001).
   PubMedGoogle Scholar
• Aksoy DY, Kerimoglu U, Okur H et al. Effects of prophylactic thyroid hormone replacement in euthyroid Hashimoto’s thyroiditis. Endocr. J.52, 337–343 (2005).
   PubMed Web of Science ®Google Scholar
• Konno N, Yuri K, Taguchi H et al. Screening for thyroid diseases in an iodine sufficient area with sensitive thyrotrophin assays, and serum thyroid autoantibody and urinary iodide determinations. Clin. Endocrinol.38, 273–281 (1993).
   PubMed Web of Science ®Google Scholar
• Eising EG, Jentzen W, Freudenberg L et al. Value of low levels of anti-TPO antibodies in patients with suspicion of hashimoto thyroiditis. Endocrinologist17, 83–84 (2007).
   Google Scholar
• Solerte SB, Precerutti S, Gazzaruso C et al. Defect of a subpopulation of natural killer immune cells in Graves’ disease and Hashimoto’s thyroiditis: normalizing effect of dehydroepiandrosterone sulfate. Eur. J. Endocrinol.152, 703–712 (2005).
   PubMedGoogle Scholar
• Crosbie D, Black C, McIntyre L et al. Dehydroepiandrosterone for systemic lupus erythematosus. Cochrane Database Syst. Rev.4, CD005114 (2007).
   Google Scholar
• Röntzsch A, Thoss K, Petrow PK, Henzgen S, Bra¨uer R. Amelioration of murine antigen-induced arthritis by dehydroepiandrosterone (DHEA). Inflamm. Res.53, 189–198 (2004).
   PubMedGoogle Scholar
• Gleicher N, Ryan E, Weghofer A et al. Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study. Reprod. Biol. Endocrinol.7, 108–114 (2009).
   PubMed Web of Science ®Google Scholar
• López-Marure R, Contreras PG, Dillon JS. Effects of dehydroepiandrosterone on proliferation, migration, and death of breast cancer cells. Eur. J. Pharmacol.660, 268–274 (2011).
   PubMed Web of Science ®Google Scholar